InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Hunt Ronald, Director. Officer active across 3 companies, notably Rallybio Corp. In total, 16 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €12.5m. History available since 11 January 2021. The latest transaction was filed on 8 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hunt Ronald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
182,453 sharesOrdinary SharesSEC:0000950170-24-095094:0
424 shares0Common StockSEC:0000950170-24-029446:0
1,072 shares0Common StockSEC:0000950170-24-000960:0
5,000 shares0Common StockSEC:0001209191-23-056796:0
1,372,000 sharesCommon StockSEC:0001209191-23-053737:0
Canonical exit: 23 Jan 2024 (T+90)
5,479 sharesOrdinary SharesSEC:0001209191-23-050912:0
3,035 shares0Common StockSEC:0001209191-23-051149:0
18,656 shares0Common StockSEC:0001209191-23-041671:0
2,796 sharesOrdinary SharesSEC:0001209191-23-040405:0
18,285 shares0Common StockSEC:0001209191-23-022802:0
2,041 shares0Ordinary SharesSEC:0001209191-23-022424:0
10,000 shares@ US$1,000.0058.4% of flow8.000% Series A Redeemable Preferred StockSEC:0000899243-23-009741:0
Canonical exit: 21 Jun 2023 (T+90)
1,197 sharesOrdinary SharesSEC:0001209191-23-001286:0
36,798 sharesOrdinary SharesSEC:0001209191-22-039314:0
235,294 shares@ US$17.0026.3% of flowCommon StockSEC:0000899243-21-032747:0
Canonical exit: 11 Apr 2021 (T+90)
1,993,911 sharesCommon StockSEC:0000899243-21-031634:0
16 of 16 declarations
About Hunt Ronald
HUNT RONALD is Administrateur at Harpoon Therapeutics, Inc., Iterum Therapeutics plc and Rallybio Corp. The 16 filings recorded cover transactions from 2021-08-04 to 2024-08-12, with EUR 12481698 of purchases and EUR 0 of sales in the sampled recent filings, and the most common transaction nature being Levée d'options.
